|
KMID : 0620920190510120151
|
|
Experimental & Molecular Medicine
2019 Volume.51 No. 12 p.151 ~ p.151
|
|
|
Autophagy-activating strategies to promote innate defense against mycobacteria
|
|
Kim Yi-Sak
Silwal Prashanta
Kim Soo-Yeon
Yoshimori Tamotsu
Jo Eun-Kyeong
|
|
|
Abstract
|
|
|
|
Mycobacterium tuberculosis (Mtb) is a major causal pathogen of human tuberculosis (TB), which is a serious health burden worldwide. The demand for the development of an innovative therapeutic strategy to treat TB is high due to drug-resistant forms of TB. Autophagy is a cell-autonomous host defense mechanism by which intracytoplasmic cargos can be delivered and then destroyed in lysosomes. Previous studies have reported that autophagy-activating agents and small molecules may be beneficial in restricting intracellular Mtb infection, even with multidrug-resistant Mtb strains. Recent studies have revealed the essential roles of host nuclear receptors (NRs) in the activation of the host defense through antibacterial autophagy against Mtb infection. In particular, we discuss the function of estrogen-related receptor (ERR) α and peroxisome proliferator-activated receptor (PPAR) α in autophagy regulation to improve host defenses against Mtb infection. Despite promising findings relating to the antitubercular effects of various agents, our understanding of the molecular mechanism by which autophagy-activating agents suppress intracellular Mtb in vitro and in vivo is lacking. An improved understanding of the antibacterial autophagic mechanisms in the innate host defense will eventually lead to the development of new therapeutic strategies for human TB.
|
|
|
KEYWORD
|
|
|
Autophagy, Medical research
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
    
|